NO20030781L - Prodrugs til NMDA-reseptor-ligander - Google Patents
Prodrugs til NMDA-reseptor-liganderInfo
- Publication number
- NO20030781L NO20030781L NO20030781A NO20030781A NO20030781L NO 20030781 L NO20030781 L NO 20030781L NO 20030781 A NO20030781 A NO 20030781A NO 20030781 A NO20030781 A NO 20030781A NO 20030781 L NO20030781 L NO 20030781L
- Authority
- NO
- Norway
- Prior art keywords
- prodrugs
- nmda receptor
- receptor ligands
- compounds
- lower alkyl
- Prior art date
Links
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 title abstract 2
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 title abstract 2
- 229940002612 prodrug Drugs 0.000 title abstract 2
- 239000000651 prodrug Substances 0.000 title abstract 2
- 239000003446 ligand Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- -1 cyclic tertiary amine Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Oppfinnelsen angår forbindelser med den generelle formel. hvor R er a) -C(0)(CH),C(0)OH,b) hvor R1 er -N(R)(R) og R/Ruavhengig er av hverandre hydrogen eller lavere alkyl, eller er a cyklisk tertiær amin, eventuelt substituert med lavere alkyl, c) -P(0)(OH)2 eller er d) - C(0)(CH),NHC(0)(CH),N(R)(R); og n er 1, 2, 3 eller 4 og farmasøytisk akseptable syreaddisjonssalter derav. Disse forbindelser kan anvendes som prodrugs for stamforbindelsen med formel. som er anvendelige ved behandling av NMDA reseptor-relaterte sykdommer.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00117918 | 2000-08-21 | ||
| PCT/EP2001/009561 WO2002016321A1 (en) | 2000-08-21 | 2001-08-20 | Prodrugs to nmda receptor ligands |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20030781D0 NO20030781D0 (no) | 2003-02-19 |
| NO20030781L true NO20030781L (no) | 2003-02-19 |
| NO324941B1 NO324941B1 (no) | 2008-01-07 |
Family
ID=8169594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20030781A NO324941B1 (no) | 2000-08-21 | 2003-02-19 | Forlopere til NMDA-reseptor-ligander, preparater inneholdende slike forbindelser, fremgangsmate for fremstilling av slike, slike forbindelser for behandling av sykdommer samt anvendelse av disse for fremstilling av preparater for behandling av sykdommer |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US6407235B1 (no) |
| EP (1) | EP1313703B1 (no) |
| JP (1) | JP4162991B2 (no) |
| KR (1) | KR100589991B1 (no) |
| CN (1) | CN1227230C (no) |
| AR (1) | AR030373A1 (no) |
| AT (1) | ATE386022T1 (no) |
| AU (2) | AU2001285894B2 (no) |
| BR (1) | BR0113348A (no) |
| CA (1) | CA2419279C (no) |
| CY (1) | CY1107937T1 (no) |
| CZ (1) | CZ303319B6 (no) |
| DE (1) | DE60132782T2 (no) |
| DK (1) | DK1313703T3 (no) |
| EC (1) | ECSP034489A (no) |
| EG (1) | EG24293A (no) |
| ES (1) | ES2299508T3 (no) |
| HK (1) | HK1059083A1 (no) |
| HR (1) | HRP20030125B1 (no) |
| HU (1) | HU229802B1 (no) |
| IL (1) | IL154254A0 (no) |
| JO (1) | JO2289B1 (no) |
| MA (1) | MA26947A1 (no) |
| MX (1) | MXPA03001311A (no) |
| MY (1) | MY136065A (no) |
| NO (1) | NO324941B1 (no) |
| NZ (1) | NZ523990A (no) |
| PA (1) | PA8525601A1 (no) |
| PE (1) | PE20020291A1 (no) |
| PL (1) | PL204215B1 (no) |
| PT (1) | PT1313703E (no) |
| RS (1) | RS51467B (no) |
| RU (1) | RU2272027C2 (no) |
| SI (1) | SI1313703T1 (no) |
| WO (1) | WO2002016321A1 (no) |
| ZA (1) | ZA200300894B (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ20023145A3 (cs) * | 2000-03-21 | 2003-01-15 | The Procter And Gamble Company | Heterocyklický postranní řetězec obsahující N-substituované inhibitory metaloproteas a farmaceutický přípravek s jejich obsahem |
| US6713490B2 (en) | 2002-04-26 | 2004-03-30 | Pfizer, Inc. | 3,4-dihydroquinolin-2(1H)-one compounds as NR2B receptor antagonists |
| US8759400B2 (en) * | 2005-12-19 | 2014-06-24 | Methylgene Inc. | Histone deacetylase inhibitors for enhancing activity of antifungal agents |
| US8796330B2 (en) * | 2006-12-19 | 2014-08-05 | Methylgene Inc. | Inhibitors of histone deacetylase and prodrugs thereof |
| KR20090094383A (ko) | 2006-12-19 | 2009-09-04 | 메틸진 인크. | 히스톤 탈아세틸화효소의 억제제 및 이의 프로드럭 |
| PT3066091T (pt) | 2013-11-05 | 2019-07-11 | Astrazeneca Ab | Pro-farmacos de antagonista de nmda |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4410822A1 (de) | 1994-03-24 | 1995-09-28 | Schering Ag | Neue Piperidin-Derivate |
| TW498067B (en) | 1996-07-19 | 2002-08-11 | Hoffmann La Roche | 4-hydroxy-piperidine derivatives |
| TWI254043B (en) | 1999-06-08 | 2006-05-01 | Hoffmann La Roche | Ethanesulfonyl-piperidine derivatives having good affinity to N-methyl-D-aspartate (NMDA) receptor |
-
2001
- 2001-08-16 PE PE2001000820A patent/PE20020291A1/es not_active Application Discontinuation
- 2001-08-16 PA PA20018525601A patent/PA8525601A1/es unknown
- 2001-08-16 US US09/931,431 patent/US6407235B1/en not_active Expired - Lifetime
- 2001-08-17 MY MYPI20013876A patent/MY136065A/en unknown
- 2001-08-17 AR ARP010103939A patent/AR030373A1/es active IP Right Grant
- 2001-08-19 JO JO2001136A patent/JO2289B1/en active
- 2001-08-20 MX MXPA03001311A patent/MXPA03001311A/es active IP Right Grant
- 2001-08-20 PT PT01965201T patent/PT1313703E/pt unknown
- 2001-08-20 CA CA002419279A patent/CA2419279C/en not_active Expired - Fee Related
- 2001-08-20 DK DK01965201T patent/DK1313703T3/da active
- 2001-08-20 KR KR1020037002485A patent/KR100589991B1/ko not_active IP Right Cessation
- 2001-08-20 BR BR0113348-9A patent/BR0113348A/pt not_active Application Discontinuation
- 2001-08-20 WO PCT/EP2001/009561 patent/WO2002016321A1/en active IP Right Grant
- 2001-08-20 NZ NZ523990A patent/NZ523990A/en not_active IP Right Cessation
- 2001-08-20 ES ES01965201T patent/ES2299508T3/es not_active Expired - Lifetime
- 2001-08-20 JP JP2002521197A patent/JP4162991B2/ja not_active Expired - Fee Related
- 2001-08-20 EG EG20010906A patent/EG24293A/xx active
- 2001-08-20 DE DE60132782T patent/DE60132782T2/de not_active Expired - Lifetime
- 2001-08-20 CZ CZ20030492A patent/CZ303319B6/cs not_active IP Right Cessation
- 2001-08-20 RS YUP-130/03A patent/RS51467B/sr unknown
- 2001-08-20 HU HU0301548A patent/HU229802B1/hu not_active IP Right Cessation
- 2001-08-20 IL IL15425401A patent/IL154254A0/xx not_active IP Right Cessation
- 2001-08-20 AU AU2001285894A patent/AU2001285894B2/en not_active Ceased
- 2001-08-20 EP EP01965201A patent/EP1313703B1/en not_active Expired - Lifetime
- 2001-08-20 CN CNB01814361XA patent/CN1227230C/zh not_active Expired - Fee Related
- 2001-08-20 AU AU8589401A patent/AU8589401A/xx active Pending
- 2001-08-20 RU RU2003107572/04A patent/RU2272027C2/ru not_active IP Right Cessation
- 2001-08-20 SI SI200130812T patent/SI1313703T1/sl unknown
- 2001-08-20 AT AT01965201T patent/ATE386022T1/de active
- 2001-08-20 PL PL361387A patent/PL204215B1/pl unknown
-
2003
- 2003-01-31 ZA ZA200300894A patent/ZA200300894B/en unknown
- 2003-02-19 NO NO20030781A patent/NO324941B1/no not_active IP Right Cessation
- 2003-02-20 HR HR20030125A patent/HRP20030125B1/xx not_active IP Right Cessation
- 2003-02-20 EC EC2003004489A patent/ECSP034489A/es unknown
- 2003-02-21 MA MA27052A patent/MA26947A1/fr unknown
-
2004
- 2004-03-16 HK HK04101906A patent/HK1059083A1/xx not_active IP Right Cessation
-
2008
- 2008-05-08 CY CY20081100485T patent/CY1107937T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR034268A1 (es) | Compuestos derivados de piperidina, su uso en preparacion de medicamentos, composicion farmaceutica, metodo de tratamiento y proceso para su preparacion | |
| HUP0402225A2 (hu) | Makrolid-vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0400682A2 (hu) | 5-Hidroxitriptamin-6-ligandumként használható heterociklilalkilindol- és -azaindol-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| NO20054669L (no) | Substituerte kinobenzoxazinanaloger | |
| BRPI0409471A (pt) | processo para a preparação de 2-cianopirrolidinas n-substituìdas | |
| DK1301526T3 (da) | Fremgangsmåde til oxidation til fremstilling af mellemproduktet 6.alpha.,9alpha.-difluor-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-on 17.beta-carboxylsyre | |
| NO20030781L (no) | Prodrugs til NMDA-reseptor-ligander | |
| NO20040388L (no) | Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten | |
| IS6452A (is) | Ný tetrahýdrópýridín, framleiðsluaðferð og lyfjasamsetningar sem innihalda þau | |
| DK0498718T3 (da) | Anvendelse af 4-(3-trifluormethylphenyl)-1,2,3,6-tetrahydropyridinderivater som indfangere af frie radikaler | |
| AR057555A1 (es) | Un inhibidor de fosfodiesterasa-4 4-oxo-1-(3-sustituido fenil-1,4-dihidro-1,8-naftiridin-3-carboxamida y un procedimiento de preparacion del mismo | |
| MY110450A (en) | Imidazolylmethyl-pyridines, their production their use as pharmaceuticals and pharmaceutical compositions containing them | |
| HUP0203315A2 (hu) | Eljárás pikonavírus ellenes hatású izoxazolkarboxamid-származékok előállítására és intermedier vegyületeik | |
| JO2433B1 (en) | Preparation of heterocyclic lindane landscapes | |
| GB0127568D0 (en) | Chemical compounds | |
| DK1347965T3 (da) | Hidtil ukendte desloratidinsalte, fremgangsmåde til syntese deraf samt farmaceutiske præparater deraf | |
| MEP12408A (en) | Acyloxypyrrolidine derivatives and use thereof as ligands of v1b or both v1b and v1a receptors | |
| HUP0302820A2 (hu) | CNS rendellenességek kezelésében hasznos indolszármazékok és ezeket tartalmazó gyógyszerkészítmények | |
| DK1347960T3 (da) | Fremgangsmåde til fremstilling af (+/-) trans-4-p-fluorphenyl-3-hydromethyl-1-methylpiperidin | |
| HUP0201195A2 (hu) | Új vegyületek, eljárás előállításukra, felhasználásuk pigmentként és kozmetikai készítményekként | |
| DE69818051D1 (de) | N-benzenesulfonyl-l-prolin-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung | |
| TH83340B (th) | สารประกอบชนิดใหม่ | |
| EP1408025A4 (en) | 3, 3-DIALCOXY-2-HYDROXYIMINOPROPIONITRILES, PROCESS FOR THE PREPARATION, AND PROCESS FOR THE PRODUCTION OF 5-AMINO-4-NITROSOPYRAZOLES, OR CORRESPONDING SALTS THEREOF THROUGH THESE NITRILES | |
| TH45494A (th) | การเตรียมพิเพอริดิน-4-โอนซึ่งถูกแทนที่ | |
| NO20010332D0 (no) | Nye 6-deoksyerytromycinderivater, metoder for fremstilling av disse, og anvendelse som medisiner |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: EVOTEC INTERNATIONAL GMBH, DE |
|
| MM1K | Lapsed by not paying the annual fees |